Search Ontology:
ChEBI

paroxetine

Term ID
CHEBI:7936
Synonyms
  • (-)-(3S,4R)-4-(p-fluorophenyl)-3-((3,4-(methylenedioxy)phenoxy)methyl)piperidine
  • (3S,4R)-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine
  • (3S-trans)-3-((1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine
  • paroxetina
  • Paroxetine
  • paroxetinum
Definition
A benzodioxole that consists of piperidine bearing 1,3-benzodioxol-5-yloxy)methyl and 4-fluorophenyl substituents at positions 3 and 4 respectively; the (3S,4R)-diastereomer. Highly potent and selective 5-HT uptake inhibitor that binds with high affinity to the serotonin transporter (Ki = 0.05 nM). Ki values are 1.1, 350 and 1100 nM for inhibition of [3H]-5-HT, [3H]-l-NA and [3H]-DA uptake respectively. Displays minimal affinity for α1-, α2- or β-adrenoceptors, 5-HT2A, 5-HT1A, D2 or H1 receptors at concentrations below 1000 nM, however displays weak affinity for muscarinic ACh receptors (Ki = 42 nM). Antidepressant and anxiolytic in vivo.
References
  • cas:61869-08-7
  • drugbank:DB00715
  • drugcentral:2068
  • kegg.compound:C07415
  • kegg.drug:D02362
  • lincs.smallmolecule:LSM-2843
  • pubmed:11009210
  • pubmed:11169163
  • pubmed:11271409
  • pubmed:11281965
  • pubmed:11324355
  • pubmed:11360029
  • pubmed:11513198
  • pubmed:11563413
  • pubmed:11565622
  • pubmed:11819027
  • pubmed:11893234
  • pubmed:11910269
  • pubmed:12027788
  • pubmed:12088162
  • pubmed:12369443
  • pubmed:12421645
  • pubmed:12818234
  • pubmed:12820211
  • pubmed:12906023
  • pubmed:12920419
  • pubmed:14516531
  • pubmed:14521492
  • pubmed:14566196
  • pubmed:14566200
  • pubmed:14619895
  • pubmed:14624192
  • pubmed:14673053
  • pubmed:14689334
  • pubmed:14978354
  • pubmed:15048901
  • pubmed:15199661
  • pubmed:15241233
  • pubmed:15264994
  • pubmed:15374134
  • pubmed:15376524
  • pubmed:15544025
  • pubmed:15613191
  • pubmed:15845695
  • pubmed:15853570
  • pubmed:15903129
  • pubmed:15963219
  • pubmed:15992089
  • pubmed:16395417
  • pubmed:16397315
  • pubmed:16426087
  • pubmed:16765127
  • pubmed:16822276
  • pubmed:16913391
  • pubmed:17122538
  • pubmed:17162096
  • pubmed:17219219
  • pubmed:17286545
  • pubmed:17452166
  • pubmed:17559097
  • pubmed:17612590
  • pubmed:17652957
  • pubmed:17874333
  • pubmed:18273418
  • pubmed:18345955
  • pubmed:18808757
  • pubmed:18983224
  • pubmed:19687003
  • pubmed:19851065
  • pubmed:21404089
  • pubmed:21452176
  • pubmed:21739267
  • pubmed:21908494
  • pubmed:21909633
  • pubmed:21922171
  • pubmed:21939725
  • pubmed:22153922
  • pubmed:22198456
  • pubmed:22212003
  • pubmed:22240860
  • pubmed:22263916
  • pubmed:22283559
  • pubmed:22353759
  • pubmed:22377745
  • reaxys:7467879
  • wikipedia.en:Paroxetine
Ontology
ChEBI  ( EBI )
Resources
CTD
Relationships
Phenotype
Phenotype resulting from paroxetine
Phenotype where environments contain paroxetine
Phenotype modified by environments containing paroxetine
Phenotype affecting paroxetine
Human Disease Model